intervention,"Active, not recruiting",Completed,Enrolling by invitation,Recruiting,Terminated,Total
NA,43,109,29,299,1,481
questionnaire,6,29,3,53,1,92
no intervention,6,6,2,27,0,41
blood sample,1,2,0,23,0,26
pcr,4,7,2,11,0,24
online survey,1,3,2,10,0,16
serology test,1,2,2,10,0,15
observational,2,1,0,8,0,11
saliva,0,1,1,8,0,10
survey,2,6,0,2,0,10
biological samples,1,0,1,6,0,8
covid-19,1,1,0,6,0,8
lung ultrasound,1,0,1,6,0,8
exposure,1,2,0,4,0,7
standard care,0,2,0,5,0,7
ct-scan,1,1,0,4,0,6
igm/igg rapid test,0,2,2,2,0,6
observation,0,2,0,4,0,6
prone positioning,2,3,0,1,0,6
ace inhibitor,1,2,0,2,0,5
data collection,0,0,0,5,0,5
hydroxychloroquine,2,3,0,0,0,5
igg antibody test,0,2,2,1,0,5
interview,1,1,0,3,0,5
quality-of-life assessment,0,0,0,5,0,5
serum test,0,1,0,4,0,5
biospeciman collection,0,0,0,4,0,4
biospecimen collection,0,0,0,4,0,4
convalescent plasma,1,1,0,2,0,4
covid-19 pandemic,1,1,0,2,0,4
exercise,0,0,1,3,0,4
ivermectin,0,4,0,0,0,4
ultrasound,0,1,0,3,0,4
arb,1,0,0,2,0,3
clinical assessment,0,2,0,1,0,3
data record,0,0,0,3,0,3
ecg,0,0,0,3,0,3
echocardiography,0,2,0,1,0,3
flow cytometry,0,2,0,1,0,3
igg,0,1,1,1,0,3
igm,0,0,1,2,0,3
interleukin,1,0,0,2,0,3
nasopharyngeal swab,0,0,0,3,0,3
non-interventional,0,1,0,2,0,3
other,0,1,0,2,0,3
rapid test,1,2,0,0,0,3
taste,0,0,0,3,0,3
acute kidney injury,0,1,0,1,0,2
appendectomy,0,2,0,0,0,2
assessment of work-related stress,0,1,0,1,0,2
azithromycin,1,1,0,0,0,2
biological data,2,0,0,0,0,2
blood test,1,0,0,1,0,2
cardiac,0,1,0,1,0,2
cardiac/electrodermal recordings,0,1,0,1,0,2
chest ct,0,2,0,0,0,2
clinical data,2,0,0,0,0,2
clinical features,0,1,0,1,0,2
corticosteroids,1,0,0,1,0,2
dalteparin,0,2,0,0,0,2
diagnostic laboratory biomarker analysis,0,0,0,2,0,2
diagnostic test,0,1,0,1,0,2
dialysis,1,0,0,1,0,2
electrodermal recordings,0,1,0,1,0,2
electronic health record review,0,0,0,2,0,2
elisa,0,2,0,0,0,2
emotional stimulation,0,1,0,1,0,2
file scanning,0,1,0,1,0,2
igm antibodytest,0,2,0,0,0,2
ion mobility spectrometry (ims),0,0,0,2,0,2
mask,0,1,0,1,0,2
methylprednisolone,0,1,0,1,0,2
mri,0,0,0,2,0,2
nasal,0,0,0,2,0,2
oxygen,0,0,0,2,0,2
practice details,0,2,0,0,0,2
pulmonary rehabilitation,0,1,0,1,0,2
quality of life,0,0,1,1,0,2
remdesivir,0,0,0,2,0,2
sample collection,0,0,0,2,0,2
sampling,0,0,0,2,0,2
sars-cov-2,0,1,0,1,0,2
semi-directive interview,0,0,0,2,0,2
spirometry,0,0,0,2,0,2
telehealth,0,1,1,0,0,2
throat swab,0,1,0,1,0,2
tinzaparin,0,2,0,0,0,2
tinzaparin/dalteparin,0,2,0,0,0,2
tocilizumab,0,0,0,2,0,2
ultrasonography,0,1,0,1,0,2
vitamin d,0,1,0,1,0,2
whole exome sequencing,0,0,0,2,0,2
": igg, ig m serologies in the amniotoc fluid, the blood cord",0,0,0,1,0,1
[68ga]ga-dota-(rgd)2 pet,0,0,0,1,0,1
[68ga]ga-dota-(rgd)2 pet/ct,0,0,0,1,0,1
[timp-2]*[igfbp-7],0,1,0,0,0,1
10 to 14 days later,0,0,0,1,0,1
2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks,0,0,0,1,0,1
25 post icu-patients,0,0,0,1,0,1
25 post non-icu patients,0,0,0,1,0,1
40-steps-test,0,0,0,1,0,1
40ml blood sample,0,0,1,0,0,1
6 weeks after delivery,0,0,0,1,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level",0,0,1,0,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level/quality of life/questioning exercise habits before/after the covid-19 outbreak in patients with behã§et/fmf.",0,0,1,0,0,1
abpm,0,0,0,1,0,1
ace inhibitor/arb,1,0,0,0,0,1
ace inhibitors/calcium channel blockers,0,1,0,0,0,1
ace/arb,0,0,0,1,0,1
active covid-19 disease,0,0,0,1,0,1
activity,0,1,0,0,0,1
adam sensor,0,0,0,1,0,1
adaptation at work score (psas),0,1,0,0,0,1
"adaptive immune response, complement activation,",0,0,0,1,0,1
admission to icu for covid-19,0,1,0,0,0,1
aerosol box,0,1,0,0,0,1
after covid-19 pandemic,0,0,0,1,0,1
after the covid-19 outbreak in patients with behã§et,0,0,1,0,0,1
ai model,1,0,0,0,0,1
airwave oscillometry,0,0,0,1,0,1
airway pressure release ventilation,0,1,0,0,0,1
alexa amazon,0,0,0,1,0,1
all treatment about covid-2019,0,0,0,1,0,1
alternate nostril breathing,0,0,0,1,0,1
anakinra,0,0,0,1,0,1
"analysis of cytokine response, innate",0,0,0,1,0,1
"analysis of cytokine response, innate/adaptive immune response, complement activation,/serum neurofilaments as a marker of neurological damage.",0,0,0,1,0,1
anesthesia management,0,1,0,0,0,1
angiotensin-converting enzyme inhibitors (ace-i)/angiotensin ii receptor blockers (arb),0,1,0,0,0,1
angiotensin ii,0,0,0,1,0,1
anne one,0,0,1,0,0,1
anti-covid test,1,0,0,0,0,1
anti-sars-cov2 serological controls,0,0,0,1,0,1
anti-sars-cov2 serological controls/serum neutralization,0,0,0,1,0,1
antibiotic,1,0,0,0,0,1
antibody test,0,0,0,1,0,1
"antibody tests,",1,0,0,0,0,1
antidiabetic treatment,0,1,0,0,0,1
antirheumatic drugs,0,0,1,0,0,1
antithrombin iii,0,0,0,1,0,1
antithrombotic therapy (anticoagulant and,0,1,0,0,0,1
antithrombotic therapy (anticoagulant and/or antiplatelet) before admission for covid19,0,1,0,0,0,1
anxiety questionnaire,0,0,0,1,0,1
anxiety),0,0,0,1,0,1
any drug used to treat covid-19,0,0,0,1,0,1
apple watch,0,0,0,1,0,1
arb blocker,0,1,0,0,0,1
arterial blood gas,0,0,0,1,0,1
assessing impact of covid19,0,0,1,0,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4,0,0,0,1,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4/6 weeks after delivery,0,0,0,1,0,1
assessment of the sequelae after hospitalization for sars-cov-2,0,0,1,0,0,1
assessment of ventilator-associated pneumonia criteria,0,0,0,1,0,1
asynchronies detection,0,1,0,0,0,1
attendance by ambulance crew,0,0,0,1,0,1
audio-visual triage system (avt),0,1,0,0,0,1
auscul-x,0,0,0,1,0,1
autopsy,0,1,0,0,0,1
axillary sweat sample,0,0,0,1,0,1
ayurvedic kadha,0,1,0,0,0,1
bariatric procedures,0,0,0,1,0,1
baricitinib,0,0,0,1,0,1
baricitinib/anakinra,0,0,0,1,0,1
beck depression inventory (bdi),0,1,0,0,0,1
behavior,1,0,0,0,0,1
behavioral,0,0,1,0,0,1
behavioral/cognitive assessment,0,0,1,0,0,1
beta interferon,0,0,0,1,0,1
biochemical analysis,0,1,0,0,0,1
biological assays in particular on the lipid metabolism,0,1,0,0,0,1
biological sample/clinical data collection,0,0,0,1,0,1
biomarkers expression,0,0,0,1,0,1
biomarkers of inflammation,0,0,0,1,0,1
"blood collection at day 8, day 16, day 24, month 6",0,0,0,1,0,1
"blood collection at day 8, day 16, day 24, month 6/month 12 after first symptoms from sars-cov-2 infection",0,0,0,1,0,1
blood collection on their first consultation/10 to 14 days later,0,0,0,1,0,1
blood sampling (venesection),0,0,0,1,0,1
"blood tests sputum, nasal lavage",0,0,0,1,0,1
"blood tests sputum, nasal lavage/brushing",0,0,0,1,0,1
bloodwork,0,0,0,1,0,1
bovhyaluronidase azoxymer,0,0,0,1,0,1
breath biopsy face masks with removable filters,0,0,0,1,0,1
breath biopsy face masks with removable filters/fitted pva strip,0,0,0,1,0,1
breath test,0,0,0,1,0,1
brushing,0,0,0,1,0,1
burnout,0,0,0,1,0,1
butterfly,0,0,0,1,0,1
bva-100,0,0,0,1,0,1
by computer consultation,0,1,0,0,0,1
c-reactive protein,0,0,0,1,0,1
c3,0,1,0,0,0,1
c3/ holter monitor,0,1,0,0,0,1
cag,0,0,0,1,0,1
calcium channel blockers,0,1,0,0,0,1
cambridge validated viral detection,0,0,0,1,0,1
capnography,0,0,0,1,0,1
cardiac ct,0,0,0,1,0,1
cardiac mri,0,0,0,1,0,1
cardiac surgery,0,0,0,1,0,1
cardiology clinical consultations,0,0,0,1,0,1
cardiopulmonary exercise test,0,0,0,1,0,1
care modalities,0,1,0,0,0,1
carotid artery reactivity testing,1,0,0,0,0,1
case fatality rate,0,1,0,0,0,1
cellular immunity,0,0,1,0,0,1
cellular response,0,1,0,0,0,1
change in preference to surgery under covid-19 pandemic.,0,1,0,0,0,1
chart review,0,0,0,1,0,1
chemotherapy,1,0,0,0,0,1
chest mri,0,0,0,1,0,1
chlorine dioxide,0,0,0,1,0,1
clinical data collection,0,0,0,1,0,1
clinical examination,0,0,0,1,0,1
clinical features/laboratory values,0,1,0,0,0,1
clinical interview,0,0,0,1,0,1
clinical observation,0,0,0,1,0,1
clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
clinical testing of subjects,0,0,0,1,0,1
"clinical, functional",0,0,0,1,0,1
"clinical, functional/radiological lung involvement evolution",0,0,0,1,0,1
"clinical, laboratory",0,0,0,1,0,1
"clinical, laboratory/imaging characteristics of pneumonia",0,0,0,1,0,1
clinico-biological parameters in routine care,0,0,0,1,0,1
closed-loop control of oxygen supplementation by o2matic,0,1,0,0,0,1
clungene rapid test cassette,0,0,0,1,0,1
cns magnetic resonance imaging (mri) imaging,0,0,0,1,0,1
cobicistat,0,0,0,1,0,1
cognitive assessment,0,0,1,0,0,1
cognitive testing,0,0,0,1,0,1
collection of breath sample,0,0,0,1,0,1
collection of mucosal lining fluid,0,1,0,0,0,1
collection of odour samples,0,0,0,1,0,1
collection of swabs,0,0,0,1,0,1
collection of tears,0,0,1,0,0,1
collection of tears/saliva.,0,0,1,0,0,1
colorectal resections,1,0,0,0,0,1
community-driven messages to promote covid-19 testing,0,0,1,0,0,1
compare the difference in respiratory rate between h0,0,0,0,1,0,1
complete thrombophilic profile testing by multiplex pcr,0,0,0,1,0,1
completion of post telemedicine encounter survey,0,1,0,0,0,1
completion of pre-pandemic survey,0,1,0,0,0,1
completion of survey after peak of pandemic,0,1,0,0,0,1
comprehensive treatment,0,0,0,1,0,1
connected devices measurements,0,0,0,1,0,1
continuous positive airway pressure (cpap) treatment,0,0,0,1,0,1
continuous renal replacement therapy,0,0,0,1,0,1
corticosteroid with,0,1,0,0,0,1
corticosteroid with/without colchicine,0,1,0,0,0,1
corticosteroids/derivatives,1,0,0,0,0,1
coviage,0,1,0,0,0,1
covicu,0,0,0,1,0,1
covid-19 / patients,1,0,0,0,0,1
covid-19 androgen sensitivity test (covast),0,0,1,0,0,1
covid-19 antibody testing,0,0,0,1,0,1
covid-19 antigen,1,0,0,0,0,1
"covid-19 antigen/antibody tests,/influenza rapid test",1,0,0,0,0,1
covid-19 experience surveys,0,0,0,1,0,1
covid-19 facility,0,1,0,0,0,1
covid-19 infection,0,0,0,1,0,1
covid-19 infection status,0,0,0,1,0,1
covid-19 infection will be conducted.,0,0,0,1,0,1
covid-19 nasal,1,0,0,0,0,1
covid-19 nasal/pharyngeal swab,1,0,0,0,0,1
covid-19 positive,0,0,0,1,0,1
covid-19 positive pregnant women,0,1,0,0,0,1
covid-19 presto test,0,0,0,1,0,1
covid-19 survey,0,0,0,1,0,1
covid-19 treatment,0,0,0,1,0,1
covid-19 treatments,0,1,0,0,0,1
covid-19 vaccine,0,0,0,1,0,1
covid-19/ observational,0,0,0,1,0,1
covid-19/intensive care,0,1,0,0,0,1
covid-antibody test,0,0,0,1,0,1
covid-surgres questionaire,0,1,0,0,0,1
covid 19 diagnostic test,1,0,0,0,0,1
covid 19 impact,0,1,0,0,0,1
covid icu containment measures,0,0,0,1,0,1
covid19 rt-pcr,0,0,0,1,0,1
covidseq test,0,0,1,0,0,1
covx,0,1,0,0,0,1
cries 13 questionnaire,0,0,0,1,0,1
cross-sectional observational study,0,1,0,0,0,1
cross-sectional study investigating the association of npis with mental health,0,1,0,0,0,1
cross sectional study using scientifically validated psychometric scales,0,1,0,0,0,1
current clinical practices of participating physicians,0,0,0,1,0,1
cystatin c,0,0,0,1,0,1
cytokines measurement,0,1,0,0,0,1
daily syndromic surveillance,0,0,1,0,0,1
darunavir,0,0,0,1,0,1
darunavir/cobicistat,0,0,0,1,0,1
dass-21 instrument (depression,0,0,0,1,0,1
dass-21 instrument (depression/anxiety),0,0,0,1,0,1
dass questionnaire,0,1,0,0,0,1
data,0,0,0,1,0,1
data collecting,0,0,0,1,0,1
data collection from blood draw,0,0,0,1,0,1
data collection from lumbar puncture,0,0,0,1,0,1
data collection from medical files,0,0,0,1,0,1
data collection up to 1 year,0,0,0,1,0,1
data collection/clinical testing of subjects,0,0,0,1,0,1
data collection: clinical care assessments,0,0,1,0,0,1
data extraction from medical files,0,0,0,1,0,1
data monitoring for 48h within the first 12 hours of admission for covid-19,0,0,0,1,0,1
"data research, database analysis",0,1,0,0,0,1
death with routine,1,0,0,0,0,1
decisions of limitations,0,0,0,1,0,1
decisions of limitations/stop processing,0,0,0,1,0,1
demographic characteristics,0,1,0,0,0,1
depression scale,0,0,0,1,0,1
"depression,",0,0,0,1,0,1
derivatives,1,0,0,0,0,1
description of groups caracteristics,0,1,0,0,0,1
device used to record voice for screening,0,0,0,1,0,1
dexamethasone,0,1,0,0,0,1
"diagnosis of sars-cov2 by rt-pcr/: igg, ig m serologies in the amniotoc fluid, the blood cord/the placenta",0,0,0,1,0,1
diagnostic examination for venous thromboembolism,0,1,0,0,0,1
diagnostic test for detection of sars-cov-2,0,0,1,0,0,1
diet tracking,0,0,0,1,0,1
"dietary counselling on food groups according to iyc feeding practices, who",0,0,0,1,0,1
differences in triage,0,1,0,0,0,1
dlco,0,0,0,1,0,1
doctor spot,0,0,0,1,0,1
dornase alfa,0,1,0,0,0,1
duplex ultrasound/computed tomography angiography,0,1,0,0,0,1
during covid-19 pandemic,0,0,0,1,0,1
dysphagia handicap index (dhi),0,0,0,1,0,1
early rehabilitation,0,0,0,1,0,1
earsats pulse oximeter probe,0,0,0,1,0,1
easycov poc,0,0,0,1,0,1
eat-26 questionnaire,0,1,0,0,0,1
eating habits,0,0,0,1,0,1
echo-doppler,0,0,0,1,0,1
echocardiogram,0,0,0,1,0,1
edinburgh postnatal depression scale (edps),0,0,0,1,0,1
education,0,1,0,0,0,1
education sessions,0,0,0,1,0,1
educational meetings/visual prompts,0,1,0,0,0,1
ei open ended pre-survey,0,0,1,0,0,1
ei open ended pre-survey/semi structured interview,0,0,1,0,0,1
elective cancer surgery,0,0,0,1,0,1
electrical impedance tomography,0,0,0,1,0,1
electro impedance tomography,0,0,0,1,0,1
electrocardiogram (ecg),0,0,0,1,0,1
"electrocardiogram, telemetry, echocardiogram, laboratory values",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography/clinico-biological parameters in routine care",0,0,0,1,0,1
"electrocardiography ,tomographic imaging",0,1,0,0,0,1
electrolytes,1,0,0,0,0,1
emergency general surgical admissions,0,1,0,0,0,1
emergency laparotomy,0,1,0,0,0,1
endoscopic management according to standard of care,0,1,0,0,0,1
environmental exposure,0,0,0,1,0,1
environmental exposure/clinical features,0,0,0,1,0,1
epds (edinburgh postnatal depression scale),0,1,0,0,0,1
epidemiological,0,1,0,0,0,1
epidemiological/demographic characteristics,0,1,0,0,0,1
equipment with smartwatch throughout hospital stay on the general ward,0,0,0,1,0,1
euroimmun assay,0,0,0,1,0,1
evaluate hacor score effectivity in this patients,0,0,0,1,0,1
"evaluation of clinical, instrumental",0,0,0,1,0,1
"evaluation of clinical, instrumental/laboratory diagnostics tests",0,0,0,1,0,1
evaluation of skin microvascular flow,0,0,0,1,0,1
evaluation of skin microvascular flow/reactivity,0,0,0,1,0,1
evaluation of the epidemiological characteristics of coronavirus infection (sars-cov-2),0,0,0,1,0,1
evaluation of the ferritin,0,0,0,1,0,1
even birth year intervention groups,0,0,0,1,0,1
examinations for the research:,0,0,0,1,0,1
examine the impact of covid-19 during pregnancy,0,0,0,1,0,1
experiences of health care professionals working in intensive care units during the covid-19 pandemic,0,0,0,1,0,1
experts consensus,0,1,0,0,0,1
exposure surveys,1,0,0,0,0,1
exposure to disinfectants during the coronavirus pandemic,0,1,0,0,0,1
exposure to the dutch measures due to the covid-19 pandemic.,0,0,0,1,0,1
extracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
extracorporeal membrane oxygenation,0,0,0,1,0,1
facial fractures reduction,0,1,0,0,0,1
facial fractures reduction/osteosynthesis,0,1,0,0,0,1
famotidine,0,1,0,0,0,1
favipiravir,0,0,0,1,0,1
favorable outcome,0,1,0,0,0,1
fecal,0,0,0,1,0,1
fibreoptic endoscopic evaluation of swallowing (fees),0,0,0,1,0,1
fibrin generation markers assays,0,0,0,1,0,1
fingertip tests for poc assays,0,0,0,1,0,1
fitted pva strip,0,0,0,1,0,1
flu shot,0,0,1,0,0,1
fmd,0,0,0,1,0,1
fmf.,0,0,1,0,0,1
follow-up of patients with covid-19,0,0,0,1,0,1
fondaparinux,0,1,0,0,0,1
fsfi survey,0,1,0,0,0,1
functional mri,0,0,0,1,0,1
further processing of health data,0,0,0,1,0,1
gad-7 (7-item generalized anxiety disorder),0,0,0,1,0,1
gad-7 (general anxiety disorder) scale,0,1,0,0,0,1
gad-7 general anxiety disorder scale,0,0,0,1,0,1
gas exchange measurement,0,1,0,0,0,1
general public cohort,0,1,0,0,0,1
generalized anxiety disorder-7 (gad-7),0,1,0,0,0,1
genetic,0,0,0,1,0,1
geneva emotional competence test (geco),0,0,1,0,0,1
global longitudinal strain,0,0,0,1,0,1
global survey,0,1,0,0,0,1
gloves,0,1,0,0,0,1
glucose control,0,0,0,1,0,1
glucose control/sensor usage,0,0,0,1,0,1
glycaemic levels,0,0,0,1,0,1
glycosylated ferritin by standard approved serological tests,0,0,0,1,0,1
"gps reports of potential patient safety incidents, non-covid-19 related",0,1,0,0,0,1
grandiosity subscales,0,0,0,1,0,1
group 1,1,0,0,0,0,1
group1,0,0,0,1,0,1
guduchi ghan vati,0,1,0,0,0,1
gustatory tests,0,0,0,1,0,1
h12 of the initiation of morphine between the control,0,0,0,1,0,1
health-related quality of life,0,0,0,1,0,1
health questionnaire,1,0,0,0,0,1
heparin,0,0,0,1,0,1
high-flow nasal cannula treatment,0,0,0,1,0,1
high flow nasal cannula,0,1,0,0,0,1
high peep with end inspiratory pause,0,0,0,1,0,1
high peep without end inspiratory pause,0,0,0,1,0,1
hip arthropalsty,0,1,0,0,0,1
holter monitor,0,1,0,0,0,1
home-use test,0,0,0,1,0,1
home sleep apnea testing,1,0,0,0,0,1
home sleep apnea testing/in-hospital polysomnography,1,0,0,0,0,1
home spirometry,0,0,0,1,0,1
hospital acquired infection,0,0,0,1,0,1
hospital anxiety,0,0,0,1,0,1
hospital anxiety depression scale,0,1,0,0,0,1
hospital anxiety/depression scale,0,0,0,1,0,1
"hospitalisation, necessity of icu, mortality rate, lung involvement",0,0,0,1,0,1
hospitalization for premature birth,0,0,1,0,0,1
hospitalized patients for covid-19 infection,0,0,0,1,0,1
host genotype,0,0,0,1,0,1
host immune factors,0,0,0,1,0,1
human milk donors,0,0,0,1,0,1
humoral,0,0,1,0,0,1
humoral/cellular immunity,0,0,1,0,0,1
id now vs. accula,0,0,0,1,0,1
ier-r (posttraumatic stress),0,0,0,1,0,1
igg antibodies assay,0,0,0,1,0,1
igg sars cov 2 antibodies,1,0,0,0,0,1
igg sars cov2,1,0,0,0,0,1
igg test,0,1,0,0,0,1
"igg, aaz, boulogne-billancourt, france)",0,0,0,1,0,1
igm test,0,0,1,0,0,1
igm/igg antibodies assay,0,0,0,1,0,1
imaging,0,0,0,1,0,1
imaging by thoracic scanner,1,0,0,0,0,1
imaging characteristics of pneumonia,0,0,0,1,0,1
"imaging, blood tests",0,1,0,0,0,1
immune response study,0,0,0,1,0,1
immunfluorescence,0,0,0,1,0,1
immunoformulation,0,1,0,0,0,1
immunoglobulin,0,1,0,0,0,1
immunoglubulins,0,0,0,1,0,1
immunological,0,0,0,1,0,1
immunosuppressive,0,0,0,1,0,1
impact event score,0,0,0,1,0,1
impulseâ„¢ una e-stethoscope,0,1,0,0,0,1
in-hospital mortality rate,0,1,0,0,0,1
individualized-chinese herbal medicine,0,0,0,1,0,1
infectious disease,0,0,0,1,0,1
infectious disease/cardiology clinical consultations,0,0,0,1,0,1
influenza rapid test,1,0,0,0,0,1
informational videos,0,0,0,1,0,1
informational videos/social media campaigns encouraging cancer screening.,0,0,0,1,0,1
informed consent,0,0,0,1,0,1
integrated clinical evaluation,0,0,0,1,0,1
intensive care,0,1,0,0,0,1
intensive care unit admission ratio,0,0,0,1,0,1
interleuken 6,0,0,0,1,0,1
interventional groups,0,0,0,1,0,1
intestinal microbiota,0,0,0,1,0,1
intracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
invasive mechanical ventilation,0,1,0,0,0,1
investigation of smell,0,0,0,1,0,1
investigation of smell/taste disorders,0,0,0,1,0,1
investigation of the prevalence of test positivity,0,0,0,1,0,1
iota carrageenan nasal spray,0,1,0,0,0,1
iota carrageenan nasal spray/ivermectin oral drops (used as buccal drops),0,1,0,0,0,1
ip-10,0,1,0,0,0,1
its,0,0,0,1,0,1
"ivermectin 5 mg/ml oral solution, aspirin 250 mg tablets",0,1,0,0,0,1
ivermectin/deamethisone/aspirin,0,1,0,0,0,1
ivermectin/deamethisone/exoparin,0,1,0,0,0,1
kaletra,0,0,0,1,0,1
kaletra/beta interferon,0,0,0,1,0,1
ketotifen,0,1,0,0,0,1
kir phenotype evaluation,0,1,0,0,0,1
"knowledge, attitude, practice, awareness, preference",0,1,0,0,0,1
lab workup (on admission,0,0,0,1,0,1
lab workup (on admission/regularly during follow up).,0,0,0,1,0,1
laboratory analyses,0,0,0,1,0,1
laboratory diagnostics tests,0,0,0,1,0,1
laboratory test positive for sars-cov-2 virus,0,0,1,0,0,1
laboratory values,0,1,0,0,0,1
labs,0,0,0,1,0,1
lamp,0,0,0,1,0,1
laparoscopic,0,1,0,0,0,1
laparoscopic/open appendicectomy,0,1,0,0,0,1
lateral position (left,0,0,0,1,0,1
lateral position (left/right lateral decubitus),0,0,0,1,0,1
lifestyle habits,0,1,0,0,0,1
liver,0,0,1,0,0,1
liver function tests,0,1,0,0,0,1
lmwh,0,1,0,0,0,1
lock-down,0,1,0,0,0,1
lock-down/social distancing,0,1,0,0,0,1
longitudinally,0,0,0,1,0,1
lopinavir,0,0,0,1,0,1
lopinavir/ritonavir,0,0,0,1,0,1
low peep - fio2 high,0,0,0,1,0,1
low peep - fio2 low,0,0,0,1,0,1
lung ct scan analysis in covid-19 patients,0,0,0,1,0,1
lung function test,0,0,1,0,0,1
lung function tests,0,0,0,1,0,1
lung ultrasound (lus),0,0,0,1,0,1
machine learning model,0,1,0,0,0,1
magec spine rod,0,0,0,1,0,1
magnetic resonance imaging,0,0,0,1,0,1
management of covid-19,0,0,0,1,0,1
management strategy of outpatient with mild to moderate sars-cov-2 pneumonia,0,1,0,0,0,1
"masimo, lidco",0,0,0,1,0,1
maslach burnout inventory (mbi),0,1,0,0,0,1
massive parallel sequencing of host genome,0,0,0,1,0,1
"maternal attachment, edinburgh depression scoring",0,1,0,0,0,1
"maternal attachment, edinburgh depression scoring/postpartum anxiety scale scores",0,1,0,0,0,1
maternal stress,0,0,0,1,0,1
mcc ims,0,1,0,0,0,1
measurement of circulating sflt1 concentration,0,0,0,1,0,1
mechanical trombectomy,0,1,0,0,0,1
mhealth assessments,0,0,0,1,0,1
microcirculation recording,0,0,0,1,0,1
microscopy of defined brain regions on autopsy specimens,0,0,0,1,0,1
mindfulness training,0,0,0,1,0,1
"ml oral solution, aspirin 250 mg tablets",0,1,0,0,0,1
"ml oral solution, dexamethasone 4-mg injection, aspirin 250 mg tablets",0,1,0,0,0,1
"ml oral solution, dexamethasone 4-mg injection, enoxaparin injection. inpatient treatment with mechanical ventilation in icu.",0,1,0,0,0,1
mmrc (modified medical research council) dyspnea scale,0,0,0,1,0,1
mobile internet survey on self-test,0,1,0,0,0,1
model building,0,1,0,0,0,1
model validation,0,1,0,0,0,1
modification,0,1,0,0,0,1
monitoring for aggravation,0,0,0,1,0,1
montelukast,0,1,0,0,0,1
month 12 after first symptoms from sars-cov-2 infection,0,0,0,1,0,1
mortality,0,0,0,1,0,1
mr-pro-adm,0,0,0,1,0,1
"mri (heart, brain, lungs, liver)",0,0,0,1,0,1
mri scans,0,0,0,1,0,1
mrna in urine test,1,0,0,0,0,1
multicapillary column coupled ion mobility spectrometry,0,0,0,1,0,1
multifrequency bioimpedance spectroscopy,0,0,0,1,0,1
muscle,1,0,0,0,0,1
musclesound ultrasound,0,0,0,1,0,1
na (no intervention),0,0,0,1,0,1
nanomix elabâ® covid-19 rapid antigen panel (non-interventional),0,0,0,1,0,1
nasal high flow,0,1,0,0,0,1
nasopharyngeal,0,1,0,0,0,1
nasopharyngeal (np) swab,1,0,0,0,0,1
nasopharyngeal/throat swab,0,1,0,0,0,1
ncapp,0,0,0,1,0,1
neural network diagnosis algorithm,0,0,0,1,0,1
newborns,0,1,0,0,0,1
news,0,1,0,0,0,1
next generation sequencing (ngs) analysis,0,0,0,1,0,1
nhanes smell,0,0,0,1,0,1
nhanes smell/taste tests,0,0,0,1,0,1
no-immunosuppressive,0,0,0,1,0,1
no intervention (survey study for medical doctors).,0,0,0,1,0,1
no intervention planned due to the observational study design only a diagnostic testing,0,0,1,0,0,1
no interventional study,1,0,0,0,0,1
non,0,0,1,0,0,1
non-acei,1,0,0,0,0,1
non-acei/arb,1,0,0,0,0,1
non-invasive ventilatory support,1,0,0,0,0,1
non interventional study,0,0,0,1,0,1
non invasive visual acuity testing,1,0,0,0,0,1
none - na,0,1,0,0,0,1
none - observational,0,0,0,1,0,1
"none, this study is observational",0,0,0,1,0,1
noninvasive ventilation,0,1,0,0,0,1
noninvasive ventilation treatment,0,0,0,1,0,1
"nose swabs, bronchoalveolar lavage ,urine)",0,0,0,1,0,1
nosocomial,0,0,0,1,0,1
not required,0,1,0,0,0,1
nps test,0,0,0,1,0,1
nricm101,0,0,0,1,0,1
nutrition,1,0,0,0,0,1
nutritional assessment,0,0,0,1,0,1
nutritional intervention,0,0,0,1,0,1
observation for study group,1,0,0,0,0,1
observation of covid 19 pneumonia,0,0,0,1,0,1
observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute),0,0,0,1,0,1
observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute)/settings,0,0,0,1,0,1
observational cohort study on the natural history of hospitalized sars-cov-2 patients.,1,0,0,0,0,1
observational measurement of biometric data. no change to health care provided.,0,0,0,1,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal",0,0,0,1,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal/saliva samples",0,0,0,1,0,1
occupational health workers,0,0,0,1,0,1
odd,0,0,0,1,0,1
odd/even birth year intervention groups,0,0,0,1,0,1
olfaction testing,0,0,0,1,0,1
olfactory,0,0,0,1,0,1
olfactory device,0,0,0,1,0,1
olfactory function evaluation,0,0,0,1,0,1
olfactory/gustatory tests,0,0,0,1,0,1
opaganib,0,1,0,0,0,1
open appendicectomy,0,1,0,0,0,1
optical coherence tomography angiography,0,1,0,0,0,1
or antiplatelet) before admission for covid19,0,1,0,0,0,1
or mis-c exposure,0,0,0,1,0,1
oropharyngeal,0,0,0,1,0,1
oropharyngeal/intestinal microbiota,0,0,0,1,0,1
orthopaedic surgical procedures,0,1,0,0,0,1
osteosynthesis,0,1,0,0,0,1
other clinical symptoms,0,1,0,0,0,1
oxidative stress elisa kit,0,0,0,1,0,1
oxygen hood,0,1,0,0,0,1
pandemic control measures,0,0,0,1,0,1
paraclinical examination,0,0,0,1,0,1
paraclinical test,0,0,0,1,0,1
passed infection of sars-cov-2,0,1,0,0,0,1
patient characteristics,0,1,0,0,0,1
patient with sar-cov-2 infection,0,0,0,1,0,1
patients,1,0,0,0,0,1
patients admitted in intensive care units,0,0,0,1,0,1
patients admitted to intensive care unit with sars-cov2,1,0,0,0,0,1
patients received standard of care treatment during hospitalization,0,0,0,1,0,1
pcr value,0,0,0,1,0,1
pcr/chest ct,0,1,0,0,0,1
pcr/serology,0,0,0,1,0,1
pct,0,0,0,1,0,1
pct/serology,1,0,0,0,0,1
peep,0,0,0,1,0,1
peer support,0,0,1,0,0,1
percutaneous coronary revascularization for stemi,1,0,0,0,0,1
performing ai algorithms on images,0,0,0,1,0,1
personal protective equipment from biological hazard,0,1,0,0,0,1
personal protective testing booth,1,0,0,0,0,1
personalized ambulatory training,0,0,0,1,0,1
pet-ct of 18f-fdg,0,1,0,0,0,1
pharyngeal swab,1,0,0,0,0,1
philips lumify ultrasound system,0,1,0,0,0,1
phlebotomy,0,0,0,1,0,1
phobia questionairre,0,0,0,1,0,1
phone interviews,0,0,0,1,0,1
phq,0,0,0,1,0,1
phq-9 depression scale,0,0,0,1,0,1
phsyiotherapy,1,0,0,0,0,1
physical activity program,0,0,0,1,0,1
physical examination,0,0,0,1,0,1
physiotherapy,0,1,0,0,0,1
pilot a rapid sars-cov-2 testing strategy,0,0,1,0,0,1
plasma igg levels,1,0,0,0,0,1
"platelet count, platelet, mean platelet volume",0,0,0,1,0,1
"platelet count, platelet, mean platelet volume/platelet distribution width in covid-19",0,0,0,1,0,1
platelet distribution width in covid-19,0,0,0,1,0,1
"platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
plethysmography,0,0,0,1,0,1
plethysmography/dlco,0,0,0,1,0,1
point-of-care test for sars-cov-2,0,0,0,1,0,1
polyoxidonium,0,1,0,0,0,1
polysomnography,1,0,0,0,0,1
pool lamp,0,0,0,1,0,1
pool rt-pcr,0,0,0,1,0,1
post-intensive care unit syndrome,0,0,0,1,0,1
post-traumatic stress screening,0,0,0,1,0,1
post covid-19 functional satus scale,0,0,0,1,0,1
postpartum anxiety scale scores,0,1,0,0,0,1
pre-operative screening,0,0,0,1,0,1
predict admission of covid-19 patients to icu,1,0,0,0,0,1
"predict admission of covid-19 patients to icu/death with routine/quickly avalaible clinical, biological/radiological variables?",1,0,0,0,0,1
predictive factors for clinical response in patients with covid-19.,0,0,0,1,0,1
predictors adverse evolution,0,0,0,1,0,1
predictors of health care provide,0,0,0,1,0,1
prevalence of covid-19,0,1,0,0,0,1
"primary care professionals reports of potential patient safety incidents, non-covid-19 related",0,0,0,1,0,1
"pro bnp , vitamin d",0,0,0,1,0,1
prognostic score,1,0,0,0,0,1
prone lying position,0,0,0,1,0,1
proper diet,0,0,0,1,0,1
prospective chart review,0,0,1,0,0,1
prospective oberservational registry,0,0,0,1,0,1
psqi,0,1,0,0,0,1
pss,0,0,0,1,0,1
psychological,1,0,0,0,0,1
psychological stress,0,1,0,0,0,1
psychological stress/adaptation at work score (psas),0,1,0,0,0,1
psychological/sociological interviews,1,0,0,0,0,1
psychometric scale administration,0,0,0,1,0,1
ptsd,0,0,0,1,0,1
public health england gold standard,0,0,0,1,0,1
pulmonary function tests,0,0,0,1,0,1
pwv,0,0,0,1,0,1
q-nrg metobolic cart device,0,0,0,1,0,1
q spect-ct,0,0,0,1,0,1
qualitative assessments of mental health,0,0,0,1,0,1
qualitative interviews..,0,0,0,1,0,1
quality of life assessment,0,1,0,0,0,1
quality of life questionnaires,0,0,0,1,0,1
quality of live assessment,0,0,0,1,0,1
quantitative,0,0,0,1,0,1
quantitative analysis of anti-sars-cov-2-antibodies,0,1,0,0,0,1
quantitative analysis of sars-cov-2 antibodies,0,1,0,0,0,1
quantitative igg test,1,0,0,0,0,1
quantitative/qualitative assessments of mental health,0,0,0,1,0,1
quantra system,0,0,1,0,0,1
quasistatic pressure-volume curve,0,0,0,1,0,1
querying the insee database,0,0,0,1,0,1
questionaire,0,1,0,0,0,1
questionnaire : preparedness for caregiving scale,0,0,0,1,0,1
"questionnaire, phone call",0,0,0,1,0,1
questionnaire/interview,0,0,0,1,0,1
questionnaires on psychological quality of life,0,1,0,0,0,1
"quickly avalaible clinical, biological",1,0,0,0,0,1
radiological,0,0,0,1,0,1
radiological lung involvement evolution,0,0,0,1,0,1
radiological variables?,1,0,0,0,0,1
radiotherapy,0,1,0,0,0,1
rapid-3,0,0,0,1,0,1
rapid molecular test,0,0,0,1,0,1
rarefaction,0,0,0,1,0,1
reactivity,0,0,0,1,0,1
recombinase,0,0,0,1,0,1
regularly during follow up).,0,0,0,1,0,1
rehabilitation,0,0,0,1,0,1
relation between frailty,0,0,0,1,0,1
relation between frailty/clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
remote pulmonary rehabilitation,0,0,0,1,0,1
repeat sars-cov-2 igg antibodies at 45-65 days,0,1,0,0,0,1
"reporting of anosmia, ageusia",0,1,0,0,0,1
"reporting of anosmia, ageusia/other clinical symptoms",0,1,0,0,0,1
research specific blood sample,0,0,0,1,0,1
respiratory mechanics measurement,0,1,0,0,0,1
respiratory monitor,0,0,0,1,0,1
respiratory monitoring,0,0,0,1,0,1
respiratory muscles ultrasound,0,0,0,1,0,1
respiratory physiotherapy,0,0,0,1,0,1
respiratory rehabilitation,0,0,0,1,0,1
respiratory swabs,0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety",0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety/depression,/post-traumatic stress screening",0,0,0,1,0,1
retrospective,0,0,0,1,0,1
retrospective case-control analysis,0,1,0,0,0,1
retrospective data collection,0,0,0,1,0,1
retrospective metagenomics on clinical samples collected during hospitalization,1,0,0,0,0,1
reverse transcription polymerase chain reaction,0,1,0,0,0,1
right lateral decubitus),0,0,0,1,0,1
risk factors,0,1,0,0,0,1
ritonavir,0,0,0,1,0,1
saliva based assay: crude rna extraction,0,0,0,1,0,1
saliva.,0,0,1,0,0,1
saliva/nps test,0,0,0,1,0,1
salivary,0,1,0,0,0,1
samba ii,0,0,0,1,0,1
sars-cov-2 ab,0,1,0,0,0,1
sars-cov-2 and,0,0,0,1,0,1
sars-cov-2 and/or mis-c exposure,0,0,0,1,0,1
sars-cov-2 antibody analysis,0,0,1,0,0,1
sars-cov-2 antibody immunoassays,1,0,0,0,0,1
sars-cov-2 antibody testing,0,0,0,1,0,1
sars-cov-2 igg,0,0,0,1,0,1
sars-cov-2 rapid diagnostic test (covid-prestoâ® igm,0,0,0,1,0,1
"sars-cov-2 rapid diagnostic test (covid-prestoâ® igm/igg, aaz, boulogne-billancourt, france)",0,0,0,1,0,1
sars-cov-2 s1,0,1,0,0,0,1
sars-cov-2 s1/s2 igg,0,1,0,0,0,1
sars-cov-2 serology,0,0,0,1,0,1
sars-cov2 infection,0,0,0,1,0,1
sars-cov2 testing,0,0,0,1,0,1
satisfaction evaluation,0,0,0,1,0,1
scanning chest x-rays/performing ai algorithms on images,0,0,0,1,0,1
sedation,0,0,0,1,0,1
self-administered questionnaire,0,1,0,0,0,1
self-reported symptom collection,0,0,0,1,0,1
semen analysis,0,1,0,0,0,1
semen qualitative analysis,1,0,0,0,0,1
semi-structured telephone questionnaire,0,0,0,1,0,1
semi structured interview,0,0,1,0,0,1
sending thorax ct video images via smartphone applications,0,1,0,0,0,1
sensor usage,0,0,0,1,0,1
sequencing,0,0,0,1,0,1
serial seroconversion measurements in hospital employees during the covid-19 pandemic,0,0,0,1,0,1
serologic assays for antibodies to sars-cov-2,0,0,0,1,0,1
serologic immunoassays to sars-cov-2 antibodies,0,0,0,1,0,1
serologic test,0,0,0,1,0,1
serological surveillance,0,0,0,1,0,1
serology test for covid-19,0,0,0,1,0,1
seroprevalence of sars-cov-2 infection in patients with hiv infection,0,0,0,1,0,1
serum neurofilaments as a marker of neurological damage.,0,0,0,1,0,1
serum neutralization,0,0,0,1,0,1
serum ngal,0,0,0,1,0,1
serum ngal/cystatin c,0,0,0,1,0,1
serum protein level analysis,0,1,0,0,0,1
service of questionnaire,0,1,0,0,0,1
settings,0,0,0,1,0,1
severe acute respiratory syndrome coronavirus 2 detection,1,0,0,0,0,1
simple chest tomography,0,1,0,0,0,1
simulation of repurposed drugs for covid-19,1,0,0,0,0,1
sivomixx,1,0,0,0,0,1
six-minute walk test (6mwt),0,0,0,1,0,1
smartphone-based voice,0,0,0,1,0,1
smartphone-based voice/self-reported symptom collection,0,0,0,1,0,1
social distancing,0,1,0,0,0,1
social media,0,1,0,0,0,1
social media campaigns encouraging cancer screening.,0,0,0,1,0,1
social media/news consumption,0,1,0,0,0,1
soluble urokinase plasminogen activator receptor,1,0,0,0,0,1
sonclot coagulation,0,1,0,0,0,1
"sonclot coagulation/platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
SOP,0,0,0,1,0,1
spartan covid-19 test,0,0,0,1,0,1
spartan covid-19 v2 system,0,0,0,1,0,1
specific anti-sars-cov-2 antibodies,0,0,0,1,0,1
specimen collection,0,0,0,1,0,1
speq (specific psychotic experiences questionnaire) - paranoia,0,0,0,1,0,1
speq (specific psychotic experiences questionnaire) - paranoia/grandiosity subscales,0,0,0,1,0,1
"spirometry, thoracic ct, cpet, 6 minute walking test, sf-36 questionnaire",0,0,1,0,0,1
st. george's respiratory questionnaire (sgrq),0,0,0,1,0,1
state-trait anxiety inventory scale,0,0,0,1,0,1
stc-19,0,1,0,0,0,1
stop processing,0,0,0,1,0,1
stress,0,0,0,1,0,1
stress/anxiety questionnaire,0,0,0,1,0,1
study a,0,0,0,1,0,1
study arm,0,0,0,1,0,1
study b,0,0,0,1,0,1
study c,0,0,0,1,0,1
study d,0,0,0,1,0,1
study of immune-mediated mechanisms in patients tested positive for sars-cov-2,0,0,0,1,0,1
subacute rehabilitation,0,0,0,1,0,1
surfactant,0,0,0,1,0,1
surge capacity,0,1,0,0,0,1
surge index,1,0,0,0,0,1
surgery,0,0,0,1,0,1
"surgery: dynamic hip screw, hemiarthroplasty, hip replacement, intramedullary nail",0,1,0,0,0,1
surgical procedure for cancer,0,0,0,1,0,1
surgical procedures performed under general anesthesia,0,1,0,0,0,1
survey/questionnaire,1,0,0,0,0,1
surveys/questionnaires,0,1,0,0,0,1
susceptibility to infection,0,0,0,1,0,1
swallowing evaluation with the eat-10,0,0,0,1,0,1
swallowing evaluation with the eat-10/the volume-viscosity swallowing test (v-vst),0,0,0,1,0,1
symptom,1,0,0,0,0,1
symptom/exposure surveys,1,0,0,0,0,1
symptoms,0,0,0,1,0,1
systemic,0,0,0,1,0,1
t-detectâ„¢ sars-cov-2 assay,0,1,0,0,0,1
taste/olfactory function evaluation,0,0,0,1,0,1
tcm,0,1,0,0,0,1
tears swab,0,1,0,0,0,1
teleconsultation,1,0,0,0,0,1
teleconsultation either by phone,0,1,0,0,0,1
teleconsultation either by phone/by computer consultation,0,1,0,0,0,1
telephone consult,0,0,0,1,0,1
tem-tpa,0,0,0,1,0,1
test,0,0,0,1,0,1
testing for sars-cov-2,1,0,0,0,0,1
testing sensitivity for sars-cov-2 virus in symptomatic individuals,0,1,0,0,0,1
"the demographic, clinical, laboratory,",0,0,0,1,0,1
"the demographic, clinical, laboratory,/instrumental data",0,0,0,1,0,1
the placenta,0,0,0,1,0,1
there is no intervention in this study,0,0,0,1,0,1
thoracic ct,0,0,0,1,0,1
thoracic ct-scan,0,0,0,1,0,1
thoracic lung ultrasound,0,0,0,1,0,1
thoraxic computed tomography,0,0,0,1,0,1
throat swab sample for measuring current infection with sars-cov-2,0,0,0,1,0,1
thrombin,0,0,0,1,0,1
thromboprophylaxis,0,1,0,0,0,1
thyroidectomy,0,1,0,0,0,1
titanium blood test,0,0,0,1,0,1
tlrs activation measurement,0,1,0,0,0,1
tof protocol,0,1,0,0,0,1
tomography angiography,0,1,0,0,0,1
tracheostomy,0,0,0,1,0,1
tracheostomy with aerosol box in covid-19 positive patients,0,1,0,0,0,1
traditional chinese medicine,0,0,0,1,0,1
training load,1,0,0,0,0,1
transparent sheet,0,1,0,0,0,1
transplant patient,1,0,0,0,0,1
transpulmonary thermodilution,0,0,0,1,0,1
treatment for covid-19,0,0,0,1,0,1
treatment group,0,0,0,1,0,1
trier social stress test,0,0,0,1,0,1
tuberculin,0,0,0,1,0,1
turkish physicians,0,1,0,0,0,1
use,0,1,0,0,0,1
use of social media during covid-19,0,1,0,0,0,1
"use of the pinpointiq solution (physiq, inc.)",0,0,1,0,0,1
use/exposure to disinfectants during the coronavirus pandemic,0,1,0,0,0,1
v,0,0,0,1,0,1
v/q spect-ct,0,0,0,1,0,1
vaccine coverage assessment,0,0,0,1,0,1
validation of the lamp assays,0,0,0,1,0,1
validation of the ngs method,0,0,0,1,0,1
validation of the poct antigen tests,0,0,0,1,0,1
venipuncture in peripheral vein,0,0,0,1,0,1
venous blood was collected for biochemistry testing,0,1,0,0,0,1
venous blood was collected for biochemistry testing.,0,0,0,1,0,1
videofluoroscopy,0,0,0,1,0,1
views,0,0,0,1,0,1
viral sequence,0,0,0,1,0,1
visual analogue scale,0,0,0,1,0,1
visual prompts,0,1,0,0,0,1
voice symptom scale (voiss),0,0,0,1,0,1
volume rapid test,0,0,0,1,0,1
vv-ecmo,0,1,0,0,0,1
walk test,0,0,0,1,0,1
web based questionnaire,0,0,1,0,0,1
weck-cel swab collection,0,0,1,0,0,1
whoqol-bref,0,0,0,1,0,1
without colchicine,0,1,0,0,0,1
x-ray,0,0,0,1,0,1
yoga,0,0,0,1,0,1
zaritt burden interview,0,0,0,1,0,1
